Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher McGuigan

Showing results (11-20 of 152) with videos related to

Pageof 16
Sort By:
Chemmedchem|September 18, 2009
Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cellsYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Organic & Biomolecular Chemistry|June 9, 2009
An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|March 17, 2010
The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTidesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Clinical Biochemistry|March 10, 2024
Autoimmune central nervous system disorders: Antibody testing and its clinical utilityMichael Gilligan, Christopher McGuigan, Andrew McKeon
Multiple Sclerosis and Related Disorders|August 18, 2019
Rash developing after cessation of Daclizumab for relapsing remitting MS; a case seriesAndrew Lockhart, Brian Kirby, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|January 15, 2011
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acidsPaul C Trippier, Jan Balzarini, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|August 17, 2010
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: monophenylboronic acidsPaul C Trippier, Christopher McGuigan, Jan Balzarini
Bioorganic & Medicinal Chemistry Letters|March 12, 2016
7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancerSahar Kandil, Andrew D Westwell, Christopher McGuigan
Irish Journal of Medical Science|September 8, 2021
Skin care advice to patients with multiple sclerosis on Fingolimod treatment at increased risk of skin malignancy-room for improvement?Lisa O'Higgins, Maria Gaughan, Christopher McGuigan, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Christopher McGuigan, Andrea Brancale, et al.
Pageof 16

Showing results (11-20 of 152) with videos related to

Sort By:
Pageof 16
Chemmedchem|September 18, 2009
Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cellsYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Organic & Biomolecular Chemistry|June 9, 2009
An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|March 17, 2010
The design, synthesis and antiviral evaluation of a series of 5-trimethylsilyl-1-beta-D-(arabinofuranosyl)uracil phosphoramidate ProTidesYoucef Mehellou, Jan Balzarini, Christopher McGuigan
Clinical Biochemistry|March 10, 2024
Autoimmune central nervous system disorders: Antibody testing and its clinical utilityMichael Gilligan, Christopher McGuigan, Andrew McKeon
Multiple Sclerosis and Related Disorders|August 18, 2019
Rash developing after cessation of Daclizumab for relapsing remitting MS; a case seriesAndrew Lockhart, Brian Kirby, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|January 15, 2011
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: bisphenylboronic acidsPaul C Trippier, Jan Balzarini, Christopher McGuigan
Antiviral Chemistry & Chemotherapy|August 17, 2010
Phenylboronic-acid-based carbohydrate binders as antiviral therapeutics: monophenylboronic acidsPaul C Trippier, Christopher McGuigan, Jan Balzarini
Bioorganic & Medicinal Chemistry Letters|March 12, 2016
7-Substituted umbelliferone derivatives as androgen receptor antagonists for the potential treatment of prostate and breast cancerSahar Kandil, Andrew D Westwell, Christopher McGuigan
Irish Journal of Medical Science|September 8, 2021
Skin care advice to patients with multiple sclerosis on Fingolimod treatment at increased risk of skin malignancy-room for improvement?Lisa O'Higgins, Maria Gaughan, Christopher McGuigan, et al.
Bioorganic & Medicinal Chemistry Letters|May 9, 2007
Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivativesYoucef Mehellou, Christopher McGuigan, Andrea Brancale, et al.
Pageof 16